SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-011198
Filing Date
2015-07-15
Accepted
2015-07-15 17:47:54
Documents
2
Period of Report
2015-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1734
2 ex24faerm.txt EX-24 4258
  Complete submission text file 0001179110-15-011198.txt   7435
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THERAVANCE, INC. 951 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Faerm Michael E. (Reporting) CIK: 0001647141 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 15990073